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ORIGINAL ARTICLE
Ethnic specific recommendations in clinical practice
guidelines: a first exploratory comparison between
guidelines from the USA, Canada, the UK, and the
Netherlands
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See editorial commentary, pp 328–9 Qual Saf Health Care 2003;12:353–358
Objectives: To investigate whether clinical practice guidelines in different countries take ethnic differ-
ences between patients into consideration and to assess the scientific foundation of such ethnic specific
recommendations.
Design: Analysis of the primary care sections of clinical practice guidelines.
Setting: Primary care practice guidelines for type 2 diabetes mellitus, hypertension, and asthma devel-
oped in the USA, Canada, the UK, and the Netherlands.
Main outcome measures: Enumeration of the ethnic specific information and recommendations in the
guidelines, and the scientific basis and strength of this evidence.
Results: Different guidelines do address ethnic differences between patients, but to a varying extent.
The USA guidelines contained the most ethnic specific statements and the Dutch guidelines the least.
Most ethnic specific statements were backed by scientific evidence, usually arising from descriptive
studies or narrative reviews.
Conclusion: The attention given to ethnic differences between patients in clinical guidelines varies
between countries. Guideline developers should be aware of the potential problems of ignoring differ-
ences in ethnicity.
Over the past 20 years clinical practice guidelines havebecome an increasingly popular tool for implementa-tion of scientifically based clinical information to
improve the quality of health care. Many countries have
produced such guidelines, mainly via specialist and/or general
practice organisations. As defined by the Institute of Medicine
(USA), clinical practice guidelines are “systematically devel-
oped statements to assist practitioner and patient decisions
about appropriate health care for specific clinical
circumstances”.1 These statements should be based on the
best available scientific evidence and practical knowledge;
however, the increasing number of clinical guidelines has
stimulated discussion about their value.2–6
An area that has received less attention in such discussions
is the “specific clinical circumstances”. Besides the disease
specific characteristics, the “specific clinical circumstances”
usually refer to the age and sex of the patient. However, with
the increase in migration to western countries during the last
50 years, these western countries have increasingly become
moremulticultural and physicians are increasingly confronted
with patients from diverse ethnic groups. In some of these
groups particular diseases can be more prevalent or more
severe, and this may also determine the patient’s clinical
circumstance.7–10 Ignorance of ethnic differences between
patients could lead to inferior quality of care for ethnic
minorities. Many potentially avoidable procedures such as
amputations, avoidable hospital admissions and readmis-
sions, avoidable pain from cancer, untreated disease, and
deaths are associated with a lower quality of care for ethnic
minorities.11 12 The question as to whether ethnicity should be
a specific clinical circumstance systematically taken into con-
sideration in clinical practice guidelines has not yet been fully
addressed. The aim of the present study was to investigate
whether clinical practice guidelines in different countries take
ethnic differences between patients into consideration, and
the scientific basis and strength of such ethnic specific recom-
mendations.
METHODS
The clinical guidelines for three prevalent and chronic health
problems—type 2 diabetes mellitus, hypertension, and
asthma—used in four western countries were examined
between 2000 and July 2001. These particular health problems
were selected because of the relatively high impact of these
diseases in western countries and because of the expected dif-
ferences between members of different ethnic groups. For
these three health problems primary care guidelines from
national organisations in the USA, Canada, the UK, and the
Netherlands were analysed (n=13; one guideline per disease
from each country except the Dutch asthma guidelines which
consisted of two separate guidelines, one for diagnostics and
one for treatment). The USA guidelines were developed by the
National Heart, Lung and Blood Institute (asthma 1997;
hypertension 1997) and the American Diabetes Association
(2001),13–15 the Canadian guidelines by the Canadian Medical
Association (asthma 1999; hypertension 1999; diabetes
1998),16–18 the British guidelines by the British Thoracic Society
(1997), the British Hypertension Society (1999), and Diabetes
UK (2000),19–21 and the guidelines used by Dutch general prac-
titioners (GPs) were developed by the Dutch College of
General Practitioners (asthma 2001; hypertension 1997;
diabetes 1999).22–25 Because some guidelines covered the whole
spectrum of care and others focused on primary care only, we
studied only the primary care sections of the different guide-
lines.
Each guideline was carefully examined (by DRM) and any
ethnic specific statement and/or recommendation made was
marked and noted. This procedure was repeated (by MAB)
and an inter-rater agreement was calculated. Consensus was
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reached in all cases of disagreement. The identified statements
were then organised into the following coherent themes:
• epidemiology (including aetiology);
• diagnostics (including screening);
• treatment (including therapy);
• patient education;
• (content of) medical record;
• (overall) cultural sensitivity.
The statements were designated either as merely empirical
information/facts or as specific recommendations in the
guidelines. The underlying scientific evidence for each ethnic
specific statement was collected by checking all the references
mentioned in the guideline for the specific statements; by
reading the evidence, the strength of the evidence was then
graded according to an adjusted version of the schemes of the
North of England guideline development project (box 1).26
RESULTS
The overall inter-rater agreement was good. Forty seven
segments of text regarding ethnic differences were identified
in the guidelines, of which 42 were identified by both authors
(inter-rater agreement: 89%). All 47 were included in the
analysis.
Ethnic specific information in diabetes guidelines
Table 1 gives the analysis of the diabetes guidelines. All four
guidelines made an empirical statement about a higher preva-
lence of diabetes among certain ethnic groups. The US, Cana-
dian and, to a lesser extent, the UK and Dutch guidelines had
some additional statements (related mainly to diagnostics/
screening) about the consequences of this higher prevalence.
The statements in the Canadian guideline were presented in a
separate section dedicated to diabetes among their aboriginal
population, except the recommendation to obtain insight into
the ethnic and cultural influences on the nutrition of the
patient.
Scientific basis of ethnic specific information in diabetes
guidelines
For diabetes the different guidelines used different sources of
evidence (research papers) for their ethnic specific statements.
The evidence was mainly type III (descriptive) prevalence
studies and all addressed their own national situation.
Ethnic specific information in hypertension guidelines
Table 2 presents the analysis of the hypertension guidelines.
The Dutch guideline contained no ethnic specific statements,
the Canadians had only one such statement (albeit an impor-
tant one), and the US and UK reported more extensively (in
separate paragraphs) about ethnic differences. The guidelines
made empirical statements about (1) a higher prevalence,
more severe hypertension, and a higher risk of complications
in certain ethnic groups; (2) the difference in response to
pharmacological treatment; and (3) the higher sensitivity to
dietary salt restriction among black subjects. These empirical
statements led to different treatment recommendations in the
respective guidelines.
Scientific basis of ethnic specific information in
hypertension guidelines
For epidemiology the evidence was primarily from type III
(descriptive) studies or narrative reviews, while the evidence
for the differential response to pharmacological treatment was
mainly from randomised controlled trials. One study (type Ib)
was used as evidence in both the US and UK guidelines.
Ethnic specific information in asthma guidelines
In the asthma guidelines (table 3) one empirical statement
about the ethnic variability of lung function was found in both
the US guideline (in a separate paragraph) and in the Dutch
guideline. The US guideline also stressed the importance of a
culture sensitive approach to the patient. The Canadian guide-
line made no ethnic specific statements, and the UK guideline
had only one minor remark about the failure of attending
education programmes.
Scientific basis of ethnic specific information in asthma
guidelines
Almost all evidence in the guidelines for asthma were based
on type III (descriptive) studies.
DISCUSSION
The results of this study show that clinical guidelines from the
four western countries do contain ethnic specific information
and recommendations, but to a varying extent. The Dutch
guidelines contained only a few empirical facts and only once
made an additional specific recommendation based on these
facts. The other three guidelines added more recommenda-
tions to the empirical facts, only for hypertension in the case
of the UK, only for diabetes in the case of Canada, but for all
three health problems in US guidelines. The US guidelines
therefore gave the most attention to ethnic differences by pre-
senting empirical facts as well as formulating specific recom-
mendations.
Because most of the statements about ethnic differences in
the different guidelines were based on differences in epidemi-
ology (prevalences), the scientific evidence used consisted
mainly of descriptive studies or narrative reviews and
addressed their national situation. The US guidelines tended
to use more evidence.
This is a first exploratory study of the attention given in
clinical practice guidelines to ethnic differences. We focused
on guidelines from only four western countries and thereby
narrowed our scope considerably. Although our comparison is
useful, it would be interesting to broaden it in further research
by including guidelines from other countries with a relatively
large group of subjects from ethnic minorities.
It is difficult to give an explanation for the difference in
focus on ethnic differences in the guidelines found in this
study because the guidelines are produced and used in the
complex environment of a healthcare system. Ethical,
economic, legal, political, and cultural aspects are involved
which vary in the different countries. Because of historical
developments, countries may have their own specific way of
Box 1 Categories of strength of evidence of
statements in clinical guidelines (developed by the
North of England evidence-based guideline
development project)
Ia: Evidence from meta-analysis of randomised controlled
trials
Ib: Evidence from at least one randomised controlled trial
IIa: Evidence from at least one controlled study without
randomisation
IIb: Evidence from at least one other type of quasi-
experimental study
III: Evidence from descriptive studies, such as comparative
studies, correlation studies and case controlled studies
IV: Evidence from expert committee reports or opinions or
clinical experience of respected authorities, or both.
IV*: Narrative reviews
*Narrative reviews could not be properly categorised into
the categories of the North of England evidence-based
guideline development project. For this reason we added
IV* to the existing categories.
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approaching ethnic differences. The USA and Canada, for
example, have a long history of being multicultural societies
with relatively large groups of native inhabitants and other
subgroups. In the UK and the Netherlands, however, ethnic
minorities are a more recent phenomenon resulting from
labour and colonial migrants. These differences in historical
background have led to political and cultural differences in
facing questions concerning minority groups. Whereas the
USA places both cultural and political emphasis on differences
in ethnic identities, other countries do this to a lesser extent,
resulting in other normative values. All these aspects could
impact on the process of guideline development—for exam-
ple, on the composition of the panel developing the guidelines
which, in turn, could influence the process of decision making
in the selection of relevant evidence and in the content of the
guidelines.6 76–80 Although guidelines are considered to be
products of evidence-based medicine and therefore primarily
based on available scientific evidence, they always contain
(either explicit or implicit) normative values of (individual)
panel members.
Another factor to consider is the possibility that, because
mainly local/national evidence was used to develop the ethnic
specific recommendations, panel members in one country
may consider that data are only applicable to ethnic groups in
the country where the research was conducted. But do
Afro-Americans in the USA differ from black subjects in the
Netherlands and the UK; and do South Asians living in the
USA differ from those in the UK, Canada or the Netherlands?
As far as the medical differences discussed in this paper are
concerned, the answer is probably not, because it is often
reported that the higher prevalence and severity of diabetes
and hypertension in certain ethnic groups and the differences
in response to drugs result, at least in part, from genetic
differences and the migration process.82 83
The above considerations raise interesting questions as to
whether cultural differences between countries can explain
different normative values between groups of guideline devel-
opers resulting in more or less ethnic specific recommenda-
tions in the guidelines, and whether health information about
certain minority ethnic groups is applicable to similar groups
in other countries. Since disease or health specific data on
white subjects are accepted worldwide, it is legitimate to
question why this does not apply to scientific data on
differences between other ethnic groups. Future research
should try to find the answers to these questions.
The development of guidelines is a complicated process in
which many heterogeneous considerations are weighed
against each other. Guidelines must be feasible and as clear,
understandable and unambiguous as possible, given current
healthcare practices. There will always be some reluctance
about changes in current practice, and in describing excep-
tions and, for example, ethnic differences.Nevertheless, ethnic
differences are present in all western societies and this issue
can expect a higher priority in future research and health care.
However, at present, the proportion of ethnic minorities in
deprived neighbourhoods in the UK and the Netherlands is
very large and, for the care in those underprivileged areas,
ethnic specific recommendations in guidelines can already
help practitioners in their daily practice and therefore should
be implemented as soon as possible. If clinical recommenda-
tions do not accept the existence of clinically relevant ethnic
differences in, for example, prevalence/complications and
Table 1 Guidelines on diabetes mellitus type 2: comparison between countries on ethnic specific statements27–40
Category Type of statement Statement about ethnic differences Country Evidence Strength
Epidemiology Empirical Higher prevalence USA Fujimoto (1987)27 III
Zimmet (1992)28 IV*
Harris (1995)29 IV*







UK No reference –




Diagnostics Recommendation Testing for diabetes at younger age or more frequently USA Harris (1995)29† IV*
CAN No reference –
Recommendation Screening if patient is 45 years (or older) and member of ethnic
group




Recommendation Aggressive screening for complications CAN No reference –
Recommendation Community based screenings programs should be established CAN Delisle (1993)31† III
Harris (1997)33† III
Recommendation Primary prevention programs initiated by Aboriginal communities
should be encouraged.
CAN Delisle (1993)31† III
Harris (1997)33† III
Recommendation In identifying patients the higher prevalence should be remembered UK No reference –
Patient education Recommendation Nutrition recommendations should consider cultural and ethnic
background
USA No reference –
CAN No reference –
Medical record Recommendation Medical history and management plan should consider important
cultural factors
USA No reference –
Cultural sensitivity Recommendation Respect for unique cultural issues CAN No reference –
*Narrative reviews.
†There was no reference mentioned for this particular statement in the guideline, but because this statement is based on information about risk factors (high
prevalences), it is probably based on the evidence about a higher prevalence in certain ethnic groups.
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response to pharmacological treatment, suboptimal or even
harmful practices may occur.84 This also applies to the need for
ethnic specific education and counselling and sensitivity
towards differences in cultural values and norms, particularly
when a positive clinical effect has been proved. By disregard-
ing scientific evidence, the guideline may provide inaccurate
information and thereby compromise the quality of care84; and
by disregarding scientific evidence, the higher morbidity and
mortality and the higher risk of complications with hyper-
tension and diabetes will continue or even get worse because,
Table 2 Guidelines on hypertension: comparison between countries on ethnic specific statements8 41–58
Category Type of statement Statement about ethnic differences Country Evidence Strength















UK Materson (1993)49 Ib
Empirical Hypertension is sensitive to dietary salt restriction in black subjects USA Weinberger (1996)52 IV*
UK No reference –
Empirical Lifestyle modifications are particularly important USA No reference –
Recommendation Black subjects require multi-drug therapy because of more severe
hypertension
USA Burt (1995)42† III
Hall (1997)46† IV*
Recommendation Achieve goal blood pressure of below 140/90 mm Hg USA Burt (1995)42† III
Hall (1997)46† IV*
Recommendation Emphasis on glucose tolerance, lipids and increased coronary risk UK McKeigue (1991)57 III
Williams (1995)58 IV
Recommendation Good blood pressure control important in South Asians with
diabetes
UK No reference –
Recommendation Aspirin and/or statin treatment may be indicated for South Asians
at high risk of CHD
UK No reference –
Recommendation The start of drug therapy should be influenced by black race CAN No reference –




Recommendation Advice to reduce fat and refined sugar intake and to increase
exercise
UK No reference –
*Narrative reviews.
†There was no reference mentioned for this particular statement in the guideline, but because this statement is based on information about risk factors (high
prevalences), it is probably based on the evidence about a higher prevalence in certain ethnic groups.
Table 3 Guidelines on asthma: comparison between countries on ethnic specific statements59–75
Category Type of statement Statement about ethnic differences Country Evidence Strength
Epidemiology Empirical Hospitalisation and death rates highest among black subjects USA CDC (1996)59 III







NL Quanjer (1983)74 IV*
Quanjer (1993)75 IV*
Patient education Empirical Failure of attending education programs is associated with
minority ethnic group
UK Fitzgerald (1994)73 IV
Recommendation Asthma education in native language and sensitive to patient’s
culture






Medical record Recommendation Sociocultural beliefs should be an item in medical history USA No reference –
*Narrative reviews.
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in the Netherlands, for example, members of the ethnic
minority groups are relatively young and will therefore be
faced with more morbidity in the future.
CONCLUSIONS
Differences in the attention given to ethnic differences
between patients in clinical practice guidelines exist between
countries. Whatever the explanations may be for these differ-
ences, guideline developers should be aware of the potential
problems for patients from ethnic minority groups. Ethnic
differences should play an important part in both screening
the available evidence and in the development of the
guideline—for example, the composition of the expert panel.
With the increasing movement of people between countries,
this aspect will become even more important in the future.
. . . . . . . . . . . . . . . . . . . . .
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